IntreTech stock price rise hits limits for 3 consecutive trading days
IntreTech stock price rise hits limits for 3 consecutive trading days in China.
The company’s announcement of abnormal fluctuations in stock transactions stated that its electronic cigarette customer PMI was authorized by the US Food and Drug Administration (“FDA”) and its IQOS product was marketed as a risk reduction tobacco product (MRTP). The company is a major supplier of precision plastic parts for IQOS electronic cigarette devices. As of now, the aforementioned information has not affected the company’s current business performance and financial data, but in the long run, it will have a positive impact on the company’s development.